Related Experiment Video

Updated: May 27, 2026

RhoC GTPase Activation Assay
09:58

RhoC GTPase Activation Assay

Published on: August 22, 2010

G-protein coupled receptor kinase 5 regulates prostate tumor growth

Jae Il Kim1, Prabir Chakraborty, Zhimin Wang

  • 1Department of Urology and Prostate Disease Center, University of Florida College of Medicine, Gainesville, Florida, USA.

The Journal of Urology
|November 22, 2011
PubMed
Abstract

Insights

G protein-coupled receptor kinases (GRKs), specifically GRK5, are crucial for prostate cancer growth. Inhibiting GRK5 kinase activity halts tumor progression and cell cycle advancement, offering new therapeutic targets.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Cancer therapeutic resistance limits treatment efficacy.
  • G protein-coupled receptor kinases (GRKs) regulate GPCR signaling and other cellular functions.
  • Identifying novel signaling pathways is crucial for developing new cancer therapies.

Purpose of the Study:

  • To investigate the role of GRK5 in prostate cancer growth and progression.
  • To determine the mechanisms by which GRK5 influences tumor development.

Main Methods:

  • Western blot analysis to assess GRK expression in prostate cancer.
  • RNA interference (RNAi) to silence GRK5 in prostate cancer cell lines.
  • Xenograft mouse models to evaluate tumor growth inhibition.
  • Cell cycle analysis to examine GRK5's impact on cell cycle progression.

Main Results:

  • GRK5 expression was significantly elevated in aggressive prostate cancer cells (PC3).
  • GRK5 silencing using RNAi reduced in vitro cell proliferation and in vivo tumor growth in mice.
  • Restoring GRK5 expression, but not its kinase-inactive mutant, reversed tumor growth inhibition.
  • GRK5 knockdown or inhibition of its kinase activity induced G2/M cell cycle arrest.
  • Loss of GRK5 activity decreased cyclin D1, phosphorylated Rb, and E2F target gene expression.

Conclusions:

  • GRK5 plays a critical role in regulating prostate tumor growth.
  • GRK5 kinase activity is essential for prostate cancer progression.
  • GRK5 represents a potential therapeutic target for prostate cancer treatment.

More Related Videos

An Orthotopic Murine Model of Human Prostate Cancer Metastasis06:48

An Orthotopic Murine Model of Human Prostate Cancer Metastasis

Published on: September 18, 2013

Related Concept Videos

GTPases and their Regulation02:14

GTPases and their Regulation

Guanine nucleotide-binding proteins (G-proteins), also known as GTPases, are a superfamily of proteins that regulate many cellular processes, such as cell signaling, vesicular transport, and the regulation of cell shape and motility. Mutation or dysfunction of these proteins can lead to disease. There are around 40,000 known G-proteins that can broadly be classified into two groups ‒  small G-proteins consisting of a single domain and large multi-domain G-proteins.
Large G-proteins, also known...
GTPases and their Regulation02:14

GTPases and their Regulation

Guanine nucleotide-binding proteins (G-proteins), also known as GTPases, are a superfamily of proteins that regulate many cellular processes, such as cell signaling, vesicular transport, and the regulation of cell shape and motility. Mutation or dysfunction of these proteins can lead to disease. There are around 40,000 known G-proteins that can broadly be classified into two groups ‒  small G-proteins consisting of a single domain and large multi-domain G-proteins.
Large G-proteins, also known...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...